ZIPDOSE

Serial Number 87762286
Registration 5752417
700

Registration Progress

Application Filed
Jan 19, 2018
Under Examination
Oct 16, 2018
Approved for Publication
Aug 21, 2018
Published for Opposition
Aug 21, 2018
Registered
May 14, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-05-14) (Grace Period Filing)
Due: Nov 14, 2025 Grace Period - 5 days
Original deadline was May 14, 2025 (overdue)

Trademark Image

ZIPDOSE

Basic Information

Serial Number
87762286
Registration Number
5752417
Filing Date
January 19, 2018
Registration Date
May 14, 2019
Published for Opposition
August 21, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 14, 2019
Registration
Registered
Classes
042

Rights Holder

Aprecia Pharmaceuticals, LLC

16
Address
7200 Industrial Row Drive, Suite 200
Mason, OH 45040

Ownership History

Aprecia Pharmaceuticals, LLC

Original Applicant
16
Blue Ash, OH

Aprecia Pharmaceuticals, LLC

Owner at Publication
16
Blue Ash, OH

Aprecia Pharmaceuticals, LLC

Original Registrant
16
Mason, OH

Legal Representation

Attorney
Brian O'Donnell

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-05-14)
Due Date
May 14, 2025
Grace Period Ends
November 14, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Mar 12, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 12, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 12, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 12, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 12, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 14, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 14, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 11, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 10, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 25, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 25, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 7, 2019 IUAF S USE AMENDMENT FILED Loading...
Mar 7, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 16, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 21, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 21, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 1, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 11, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 11, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 11, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 11, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 11, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 5, 2018 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
May 15, 2018 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Apr 28, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 28, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 1, 2018 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 31, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 31, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 31, 2018 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 23, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of pharmaceutical and nutraceutical preparations for others, namely, pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents; research and development in the pharmaceutical and nutraceutical fields for others, namely, research and development of pharmaceutical and nutraceutical compounds in a unitary solid dosage form for the rapid dispersion of a wide variety of therapeutic agents
First Use Anywhere: Jul 30, 2018
First Use in Commerce: Jul 30, 2018

Additional Information

Design Mark
The mark consists of the stylized word "ZIPDOSE" inside a rectangle with curved sides on the right and a scalloped edge on the left with nine adjacent rows of five squared dots each in graduated size from the row of largest squared dots immediately adjacent to the scalloped edge of the rectangle to the smallest.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ZIP DOSE

Classification

International Classes
042